On behalf of the Emerging Technologies Division please find below the link to the CRISPR Survey.
Traditional nucleic acid-based diagnostics have undoubtedly revolutionized disease detection, yet they come with significant challenges such as the need for specialized laboratories, expensive reagents, and trained personnel. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based diagnostics offer a promising alternative, potentially overcoming these limitations. Based on your experience and knowledge, your feedback will help to understand awareness, challenges, and limitations surrounding CRISPR-based diagnostics.
The survey will take approximately 15 minutes to complete.
No individual responses will be presented, and the privacy of individual respondents will be respected: the answers will be kept strictly confidential and only used for the purposes of this research.
https://www.surveymonkey.com/r/VH9KCH5
Deadline for completion is 16 December 2024.
Please circulate this survey to your society members. Each individual member of your society should be invited to complete and submit the survey.
If you have any questions about the survey, please contact Dr. Swarup A. V. Shah ([email protected]), member of the IFCC Emerging Technologies Division Executive Committee.
Thank you very much for your cooperation.
